References
- Di Daniele M, Asma K, Gabriele S, Giuseppe R, Danilo B, Marco L, Jacopo V, Luigi N, Giovanni S, Vincenzo B, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID 1-19) during pregnancy: a systematic review and meta-analysis. Am J Obs Gynecol MFM. 2020;PII:S2589-9333(20)30037–9. doi:https://doi.org/10.1016/j.ajogmf.2020.100107.
- Miller ES, Grobman WA, Sakowicz A, Rosati J, Peaceman AM. Clinical implications of universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in pregnancy. Obstet Gynecol. 2020 May 19;136(2):232–34. Epub ahead of print. PMID: 32433449. doi:https://doi.org/10.1097/AOG.0000000000003983.
- Dehan L, Lin L, Xin W, Dandan Z, Jiazheng W, Lian Y, Chuansheng Z. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. Am J Roentgenol. 2020;215:1–6. doi:https://doi.org/10.2214/AJR.20.23072.
- Chen L, Li Q, Zheng D, Jiang H, Wei Y, Zou L, Feng L, Xiong G, Sun G, Wang H, et al. Clinical characteristics of pregnant women with Covid-19 in Wuhan, China. N Engl J Med. 2020 Apr 17;382(25):e100. Published Online First. doi:https://doi.org/10.1056/NEJMc2009226.
- David S. An analysis of 38 pregnant women with 2 COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020. Forthcoming [published online ahead of print, 2020 March 17]. doi:https://doi.org/10.5858/arpa.2020-0901-SA.
- Chen S, Huang B, Luo DJ, Li X, Yang F, Zhao Y, Nie X, Huang BX. Pregnant women with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases. 2020. Zhonghua Bing Li Xue Za Zhi. 2020;49:E005. doi:https://doi.org/10.3760/cma.j.cn112151-20200225-00138.
- Favre G, Pomar L, Musso D, et al. 2019-nCoV epidemic: what about pregnancies? Lancet. 2020;395. (published online February 6). https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)30311-1.pdf.
- Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Denise J. Jamieson. Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020;222(5):415–26. doi:https://doi.org/10.1016/j.ajog.2020.02.017.
- Nan Y, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis. 2020. doi:https://doi.org/10.1016/S1473-3099(20)30176-6.
- Swartz DA, Graham AL. Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020;12(2):194. doi:https://doi.org/10.3390/v12020194.
- Mojgan KZ, Hossein N, Seyed AD, Hajar A, Seyed RM, Athena B, Farzad F, Reza B. Vertical transmission of coronavirus disease 19 (COVID-19) from infected pregnant mothers to neonates: a review. Fetal Pediatr Pathol. 2020. doi:https://doi.org/10.1080/15513815.2020.1747120.
- Thornton JG. COVID-19 in pregnancy. BJOG. 2020 May 7;127(9):1122–1122. Epub ahead of print. PMID: 32378774. doi:https://doi.org/10.1111/1471-0528.16308.
- Shanes ED, Mithal LB, Otero S, Azad HA, Miller ES, Goldstein JA. Placental Pathology in COVID-19. Version 2. Am J Clin Pathol. 2020 Jun 8;154(1):23–32. PMID: 32441303; PMCID: PMC7279066. doi:https://doi.org/10.1093/ajcp/aqaa089.
- Simões E Silva AC, Leal CRV. Is SARS-CoV-2 vertically transmitted? Front Pediatr. 2020 May 15;8:276. PMID: 32574285; PMCID: PMC7243472. doi:https://doi.org/10.3389/fped.2020.00276.
- Penfield CA, Brubaker SG, Limaye MA, Lighter J, Ratner AJ, Thomas KM, Meyer JA, Roman AS. Detection of severe acute respiratory syndrome coronavirus 2 in placental and fetal membrane samples. Am J Obs Gynecol MFM. doi:https://doi.org/10.1016/j.ajogmf.2020.100133.
- Juan J, Gil MM, Rong Z, Zhang Y, Yang H, Poon LC. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol. 2020 Jul;56(1):15–27. PMID: 32430957; PMCID: PMC7276742. doi:https://doi.org/10.1002/uog.22088.
- Zeng L, Xia S, Yuan W, Yan K, Xiao F, Shao J, Zhou W. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatrics. 2020;174(7):722. doi:https://doi.org/10.1001/jamapediatrics.2020.0878.
- Guidance for Management of Pregnant Women in COVID-19 Pandemic. ICMR - national institute for research in reproductive health. [accessed 1 Jul 2020] https://www.icmr.gov.in/pdf/covid/techdoc/Guidance_for_Management_of_Pregnant_Women_in_COVID19_Pandemic_12042020.pdf
- Coronavirus disease (COVID-19) technical guidance: Maintaining Essential Health Services and Systems. World health organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/maintaining-essential-health-services-and-systems
- RCOG, Royal College of Midwives, RCPCH, et al. Coronavirus (COVID-19) infection in pregnancy: information for healthcare professionals. Royal College of Obstetricians and Gynaecologists 2020; (published online 28 March) https://www.rcog.org.uk/globalassets/documents/guidelines/2020-03-28-covid19-pregnancy-guidance.pdf
- Data Reporting Status All India level data, 2019-2020. Standard reports. Health management information system (HMIS). Ministry of health & family welfare, government of India. The data is retrieved from https://nrhm-mis.nic.in/hmisreports/frmstandard_reports.aspx on 29th April, 2020
- India’s auxiliary nurse-midwife, anganwadi worker, accredited social health activist, multipurpose worker, and lady health visitor programs by: kerry Scott, Dena Javadi, and Jessica Gergen (comments from Dr. Rajani Ved and contributions from Rachel Strodel). https://www.chwcentral.org/blog/indias-auxiliary-nurse-midwife-anganwadi-worker-accredited-social-health-activist-multipurpose.
- Kelli SH, Goleen S, Samantha G, Sara EC, Dazon DD, Miriam O, Rachel TM, Micaela EM, Terry M. Centring sexual and reproductive health and justice in the global COVID-19 response. Comment. Lancet. 395:1175–77.
- Coronavirus Disease (COVID-19) Preparedness and Response - UNFPA Technical Briefs V March 23_2020. Gender equality and addressing gender-based violence (GBV) and coronavirus disease (COVID-19) prevention, protection and response.
- Contraception and COVID-19: disrupted supply and access. 15 Apr 2020. https://www.ippf.org/blogs/contraception-and-covid-19-disrupted-supply-and-access.
- Andy H, Enrique B, Anita B, David LH, Matthew JH. Centring sexual and reproductive health and justice in the global COVID-19 response. Lancet. 2020 Apr 11;395(10231):1175–77. COMMENT|. doi:https://doi.org/10.1016/S0140-6736(20)30801-1.
- Interim Technical Note: Impact of the COVID-19 Pandemic on Family Planning and Ending Gender-based Violence, Female Genital Mutilation and Child Marriage. Pandemic threatens achievement of the transformative results committed to by UNFPA. By UNFPA, with contributions from avenir health, Johns Hopkins University (USA) and Victoria University (Australia) dated 27th April 2020.
- Impact of COVID 19 on Family Planning Program. Policy Brief May 2020. FRHS India. [accessed 29 May 2020]. https://pratigyacampaign.org/wp-content/uploads/2020/05/impact-of-covid-19-on-indias-family-planning-program-policy-brief.pdf
- Vora KS, Saiyed S, Natesan S. Impact of COVID-19 on family planning services in India. Sex Reprod Health Matt. 2020 Jun 19;1–3. Epub ahead of print. PMID: 32552622. doi:https://doi.org/10.1080/26410397.2020.1785378.
- Enabling Delivery of Essential Health Services during the COVID 19 Outbreak: Guidance note. MOHFW guidelines for COVID 19. [accessed 25 Apr 2020] https://www.mohfw.gov.in/pdf/EssentialservicesduringCOVID19updated0411201.pdf
- Wenham C, Smith J, Morgan R. COVID-19: the gendered impacts of the outbreak. Lancet. 2020;395:846–48. doi:https://doi.org/10.1016/S0140-6736(20)30526-2.
- Peterman P, O’Donnell T, Shah O-P, van Gelder, 2020. Pandemics and Violence Against Women and Children. CGD Working Paper 528. Washington (DC): Center for Global Development. https://www.cgdev.org/publication/pandemics-and-violence-against-women-and-children.
- COVID-19 and violence against women What the health sector/system can do. World health organization. 26 Mar 2020. https://www.who.int/reproductivehealth/publications/emergencies/COVID-19-VAW-full-text.pdf?ua=1
- Amanat F, Krammer F. SARS-CoV-2 vaccines: status report. Immunity. 2020 Apr 14;52(4):583–89. doi:https://doi.org/10.1016/j.immuni.2020.03.007.
- Draft landscape of COVID 19 candidate vaccines. World health organization. 29 Jun 2020. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
- Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol. 2017 May 15;198(10):4046–53. doi:https://doi.org/10.4049/jimmunol.1601896.
- Klein SL, Hodgson A, Robinson DP. Mechanisms of sex disparities in influenza pathogenesis. J Leukoc Biol. 2012 Jul;92(1):67–73. doi:https://doi.org/10.1189/jlb.0811427.
- Fischinger S, Boudreau CM, Butler AL, Streeck H, Alter G. Sex differences in vaccine-induced humoral immunity. Semin Immunopathol. 2019 Mar;41(2):239–49. doi:https://doi.org/10.1007/s00281-018-0726-5.
- Klein SL, Flanagan KL. Sex differences in immune responses. Nature Rev Immunol. 2016;16:626–38. doi:https://doi.org/10.1038/nri.2016.90.
- Zeng F, Dai C, Cai P, Wang J, Xu L, Li J, Hu G, Wang Z, Zheng F, Wang L. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex. J Med Virol. 2020 May 8. doi:https://doi.org/10.1002/jmv.25989.
- Beyer WE, Palache AM, Kerstens R, Masurel N. Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies. Eur J Clin Microbiol Infect Dis. 1996 Jan;15(1):65–70. PMID: 8641306. doi:https://doi.org/10.1007/BF01586187.
- Nichol KL, Margolis KL, Lind A, Murdoch M, McFadden R, Hauge M, Magnan S, Drake M. Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial. Arch Intern Med. 1996 Jul 22;156(14):1546–50. PMID: 8687262. doi:https://doi.org/10.1001/archinte.1996.00440130090009.
- Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, et al. Walter reed health care system influenza vaccine consortium. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med. 2008 Dec 8;168(22):2405–14. PMID: 19064822. doi:https://doi.org/10.1001/archinternmed.2008.513.
- Cook IF. Sexual dimorphism of humoral immunity with human vaccines. Vaccine. 2008 Jul 4;26(29–30):3551–55. Epub 2008 May 9. PMID: 18524433. doi:https://doi.org/10.1016/j.vaccine.2008.04.054.
- Andersen A, Bjerregaard-Andersen M, Rodrigues A, Umbasse P, Fisker AB. Sex-differential effects of diphtheria-tetanus-pertussis vaccine for the outcome of paediatric admissions? A hospital based observational study from Guinea-Bissau. Vaccine. 2017;35:7018–25. doi:https://doi.org/10.1016/j.vaccine.2017.10.047.
- Agergaard J, Nante E, Poulstrup G, Nielsen J, Flanagan KL, Østergaard L, Benn CS, Aaby P. Diphtheria-tetanus-pertussis vaccine administered simultaneously with measles vaccine is associated with increased morbidity and poor growth in girls. A randomised trial from Guinea-Bissau. Vaccine. 2011;29:487–500. doi:https://doi.org/10.1016/j.vaccine.2010.10.071.
- Khalil MK 1, Al-Mazrou YY, Al-Ghamdi YS, Tumsah S, Al-Jeffri M, Meshkhas A. Effect of gender on reporting of MMR adverse events in Saudi Arabia. East Mediterr Health J. 2003;9(1–2):152–58. Jan-Mar.
- Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg. 2015 Jan;109(1):9–15. doi:https://doi.org/10.1093/trstmh/tru167.
- Gao Z, Chen Z, Sun A, Deng X. Gender differences in cardiovascular disease. Med Novel Technol Dev. 2019;4:100025. doi:https://doi.org/10.1016/j.medntd.2019.100025.
- Gomes MF, De La Fuente-Nunez V, Saxwna A, Kuesel AC. Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials. Reprod Health. 2017;14:47–55.
- Bebell LM, Oduyebo T, Riley LE. Ebola virus disease and pregnancy - A review of the current knowledge of Ebola virus pathogenesis, maternal and neonatal outcomes. Birth Defects Res. 2017 Mar 15;109(5):353–62. doi:https://doi.org/10.1002/bdra.23558.
- Schwartz DA. Clinical trials and administration of Zika virus vaccine in pregnant women: lessons (that should have been) learned from excluding immunization with the Ebola vaccine during pregnancy and lactation. Vaccines (Basel). 2018;6:81. doi:https://doi.org/10.3390/vaccines6040081.
- International ethical guidelines for health-related research involving humans. [accessed 12 May 2020]. https://cioms.ch/publications/product/international-ethical-guidelines-for-health-related-research-involving-humans/
- Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010 June;63(6):425–33. doi:https://doi.org/10.1111/j.1600-0897.2010.00836.x.
- Vojtek I, Dieussaert I, Doherty TM, Franck V, Hanssens L, Miller J, Bekkat-Berkani R, Kandeil W, Prado-Cohrs D, Vyse A. Maternal immunization: where are we now and how to move forward? Ann Med. 2018 May;50(3):193–208. doi:https://doi.org/10.1080/07853890.2017.1421320.
- Ward P et al. COVID-19 vaccine and antiviral drug development, faculty of pharmaceutical medicine blog, 8 Apr 2020. https://www.fpm.org.uk/blog/covid-19-vaccine-and-antiviral-drug-development/